Establishment of Acquired Cisplatin Resistance in Ovarian Cancer Cell Lines Characterized by Enriched Metastatic Properties with Increased Twist Expression
Ovarian cancer (OC) is the most lethal of the gynecologic cancers, and platinum-based treatment is a part of the standard first-line chemotherapy regimen. However, rapid development of acquired cisplatin resistance remains the main cause of treatment failure, and the underlying mechanism of resista...
Main Authors: | Entaz Bahar, Ji-Ye Kim, Hyun-Soo Kim, Hyonok Yoon |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/20/7613 |
Similar Items
-
Modeling and Predicting the Cell Migration Properties from Scratch Wound Healing Assay on Cisplatin-Resistant Ovarian Cancer Cell Lines Using Artificial Neural Network
by: Entaz Bahar, et al.
Published: (2021-07-01) -
Deregulation of Exo70 Facilitates Innate and Acquired Cisplatin Resistance in Epithelial Ovarian Cancer by Promoting Cisplatin Efflux
by: Yujie Zhao, et al.
Published: (2021-07-01) -
A Feedback Loop Between miR-30a/c-5p and DNMT1 Mediates Cisplatin Resistance in Ovarian Cancer Cells
by: Xi Han, et al.
Published: (2017-02-01) -
Nanotechnology-Based Cisplatin Intracellular Delivery to Enhance Chemo-Sensitivity of Ovarian Cancer
by: Bortot B, et al.
Published: (2020-07-01) -
Epithelial-mesenchymal transition in ovarian carcinoma
by: Ben eDavidson, et al.
Published: (2012-04-01)